Cubist Systematic Strategies’s Seres Therapeutics MCRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,283
| Closed | -$410K | – | 2350 |
|
|
2023
Q2 | $410K | Buy |
4,283
+3,795
| +778% | +$364K | ﹤0.01% | 1474 |
|
|
2023
Q1 | $55.4K | Sell |
488
-2,822
| -85% | -$320K | ﹤0.01% | 2512 |
|
|
2022
Q4 | $371K | Buy |
3,310
+3,301
| +36,678% | +$370K | ﹤0.01% | 2350 |
|
|
2022
Q3 | $1K | Sell |
9
-229
| -96% | -$25.4K | ﹤0.01% | 3563 |
|
|
2022
Q2 | $16K | Sell |
238
-1,944
| -89% | -$131K | ﹤0.01% | 3697 |
|
|
2022
Q1 | $311K | Sell |
2,182
-12,188
| -85% | -$1.74M | ﹤0.01% | 2799 |
|
|
2021
Q4 | $2.39M | Sell |
14,370
-1,540
| -10% | -$257K | 0.02% | 1214 |
|
|
2021
Q3 | $2.22M | Buy |
15,910
+14,525
| +1,049% | +$2.02M | 0.03% | 946 |
|
|
2021
Q2 | $660K | Buy |
+1,385
| New | +$660K | 0.01% | 1825 |
|
|
2021
Q1 | – | Sell |
-797
| Closed | -$391K | – | 2917 |
|
|
2020
Q4 | $391K | Sell |
797
-2,886
| -78% | -$1.42M | 0.01% | 1907 |
|
|
2020
Q3 | $2.09M | Buy |
3,683
+2,540
| +222% | +$1.44M | 0.03% | 876 |
|
|
2020
Q2 | $109K | Buy |
+1,143
| New | +$109K | ﹤0.01% | 2181 |
|
|
2017
Q4 | – | Sell |
-529
| Closed | -$170K | – | 2018 |
|
|
2017
Q3 | $170K | Buy |
+529
| New | +$170K | 0.01% | 1505 |
|